Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 2Phase 3 2Phase EARLY_PHASE1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Plasma cell 1Myeloid 1

Conditions

Colorectal Neoplasms 7Colonic Neoplasms 6Recurrence 4Prostatic Neoplasms 4Neoplasms 4Polycythemia Vera 3Venous Thromboembolism 2Thrombocythemia, Essential 2Rectal Neoplasms 2Myocardial Infarction 2Esophageal Neoplasms 2Cardiovascular Diseases 2Adenoma 2Vascular Diseases 1Thrombosis 1Thrombocytopenia 1Stomach Neoplasms 1Primary Myelofibrosis 1Precancerous Conditions 1Pathologic Processes 1Node Positive HER2 Negative Breast Cancer 1Neoplasms by Site 1Neoplasm Metastasis 1Myocardial Ischemia 1Myeloproliferative Disorders 1Multiple Myeloma 1Lynch syndrome I (site-specific colonic cancer) 1Lymphoma, Follicular 1Liver Cirrhosis 1Ischemic Stroke 1

Interventions

Dalteparin 8apixaban 6Rivaroxaban 6Heparin, Low-Molecular-Weight 5Tinzaparin 4Enoxaparin 4bemiparin 2abelacimab 2Warfarin 2MAA868 2Aspirin 2reviparin 1isoquercitrin 1edoxaban 1certoparin 1betrixaban 1argatroban 1acarboxyprothrombin 1Phenprocoumon 1Nadroparin 1N(4)-oleylcytosine arabinoside 1Dabigatran 1Acenocoumarol 1AVE 5026 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Venous Thromboembolism × Aspirin × Clear all
NCT05198960 2026-03-20

AVAJAK

University Hospital, Brest

Phase 3 Recruiting
1,308 enrolled
Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Not yet recruiting
530 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡